$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 15 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.17 | 100 | 817 | 2,969,606 | 3 M to 3 M (0.00 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.16 | 500 | 4,080 | 2,969,706 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.15 | 1,200 | 9,780 | 2,970,206 | 3 M to 3 M (-0.04 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.14 | 200 | 1,628 | 2,971,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.13 | 200 | 1,626 | 2,971,606 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.12 | 500 | 4,060 | 2,971,806 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.11 | 200 | 1,622 | 2,972,306 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.10 | 500 | 4,050 | 2,972,506 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.09 | 200 | 1,618 | 2,973,006 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.08 | 200 | 1,616 | 2,973,206 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.07 | 300 | 2,421 | 2,973,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.06 | 400 | 3,224 | 2,973,706 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.05 | 600 | 4,830 | 2,974,106 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.04 | 1,600 | 12,864 | 2,974,706 | 3 M to 3 M (-0.05 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.03 | 399 | 3,204 | 2,976,306 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.02 | 400 | 3,208 | 2,976,705 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.01 | 1,000 | 8,010 | 2,977,105 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.00 | 6,301 | 50,408 | 2,978,105 | 3 M to 3 M (-0.21 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.92 | 200 | 1,584 | 2,984,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.01 | 850 | 6,809 | 2,984,606 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,850 | 6,816 | 2,985,456 | 3 M to 3 M (+0.53 %) |
| Aug 07 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 52,767 | 22,690 | 962,176 | |
| Aug 07 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.20 | 2,767 | 22,689 | 3,019,606 | 3 M to 3 M (-0.09 %) |
| Aug 07 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 52,767 | 22,690 | 3,022,373 | 3 M to 3 M (+1.78 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,816 | 6,801 | 1,014,943 | |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,850 | 6,816 | 1,030,759 | |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.99 | 1,301 | 10,395 | 2,980,906 | 3 M to 3 M (-0.04 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.98 | 600 | 4,788 | 2,982,207 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.96 | 400 | 3,184 | 2,982,807 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.95 | 400 | 3,180 | 2,983,207 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.94 | 200 | 1,588 | 2,983,607 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.93 | 700 | 5,551 | 2,983,807 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.89 | 99 | 781 | 2,984,507 | 3 M to 3 M (0.00 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.33 | 816 | 6,797 | 2,984,606 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,816 | 6,801 | 2,985,422 | 3 M to 3 M (+0.53 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.17 | 100 | 817 | 2,969,606 | 3 M to 3 M (0.00 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.16 | 500 | 4,080 | 2,969,706 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.15 | 1,200 | 9,780 | 2,970,206 | 3 M to 3 M (-0.04 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.14 | 200 | 1,628 | 2,971,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.13 | 200 | 1,626 | 2,971,606 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.12 | 500 | 4,060 | 2,971,806 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.11 | 200 | 1,622 | 2,972,306 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.10 | 500 | 4,050 | 2,972,506 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.09 | 200 | 1,618 | 2,973,006 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.08 | 200 | 1,616 | 2,973,206 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.07 | 300 | 2,421 | 2,973,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.06 | 400 | 3,224 | 2,973,706 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.05 | 600 | 4,830 | 2,974,106 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.04 | 1,600 | 12,864 | 2,974,706 | 3 M to 3 M (-0.05 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.03 | 399 | 3,204 | 2,976,306 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.02 | 400 | 3,208 | 2,976,705 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.01 | 1,000 | 8,010 | 2,977,105 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.00 | 6,301 | 50,408 | 2,978,105 | 3 M to 3 M (-0.21 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.92 | 200 | 1,584 | 2,984,406 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.01 | 850 | 6,809 | 2,984,606 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,850 | 6,816 | 2,985,456 | 3 M to 3 M (+0.53 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 20,000 | 7,800 | 2,304,003 | |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.33 | 400 | 3,332 | 673,310 | 673.7 K to 673.3 K (-0.06 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.31 | 100 | 831 | 673,710 | 673.8 K to 673.7 K (-0.01 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.30 | 100 | 830 | 673,810 | 673.9 K to 673.8 K (-0.01 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.28 | 300 | 2,484 | 673,910 | 674.2 K to 673.9 K (-0.04 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.27 | 400 | 3,308 | 674,210 | 674.6 K to 674.2 K (-0.06 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.26 | 760 | 6,278 | 674,610 | 675.4 K to 674.6 K (-0.11 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.25 | 1,040 | 8,580 | 675,370 | 676.4 K to 675.4 K (-0.15 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.24 | 400 | 3,296 | 676,410 | 676.8 K to 676.4 K (-0.06 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.23 | 1,300 | 10,699 | 676,810 | 678.1 K to 676.8 K (-0.19 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.22 | 2,400 | 19,728 | 678,110 | 680.5 K to 678.1 K (-0.35 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.21 | 6,100 | 50,081 | 680,510 | 686.6 K to 680.5 K (-0.89 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.20 | 500 | 4,100 | 686,610 | 687.1 K to 686.6 K (-0.07 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.16 | 600 | 4,896 | 687,110 | 687.7 K to 687.1 K (-0.09 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.15 | 600 | 4,890 | 687,710 | 688.3 K to 687.7 K (-0.09 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.12 | 5,000 | 40,600 | 688,310 | 693.3 K to 688.3 K (-0.72 %) |
| Aug 02 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 20,000 | 7,800 | 693,310 | 673.3 K to 693.3 K (+2.97 %) |
| Jul 27 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Option Exercise | M | 0.39 | 30,000 | 11,700 | 464,638 | |
| Jul 27 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Buy | M | 0.39 | 30,000 | 11,700 | 401,410 | 371.4 K to 401.4 K (+8.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.99 | 400 | 3,996 | 371,410 | 371.8 K to 371.4 K (-0.11 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.98 | 600 | 5,988 | 371,810 | 372.4 K to 371.8 K (-0.16 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.97 | 1,329 | 13,250 | 372,410 | 373.7 K to 372.4 K (-0.36 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.96 | 400 | 3,984 | 373,739 | 374.1 K to 373.7 K (-0.11 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.95 | 500 | 4,975 | 374,139 | 374.6 K to 374.1 K (-0.13 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.94 | 300 | 2,982 | 374,639 | 374.9 K to 374.6 K (-0.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.93 | 400 | 3,972 | 374,939 | 375.3 K to 374.9 K (-0.11 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.92 | 471 | 4,672 | 375,339 | 375.8 K to 375.3 K (-0.13 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.90 | 300 | 2,970 | 375,810 | 376.1 K to 375.8 K (-0.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.89 | 300 | 2,967 | 376,110 | 376.4 K to 376.1 K (-0.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.86 | 300 | 2,958 | 376,410 | 376.7 K to 376.4 K (-0.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.85 | 200 | 1,970 | 376,710 | 376.9 K to 376.7 K (-0.05 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.84 | 500 | 4,920 | 376,910 | 377.4 K to 376.9 K (-0.13 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.83 | 100 | 983 | 377,410 | 377.5 K to 377.4 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.82 | 100 | 982 | 377,510 | 377.6 K to 377.5 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.81 | 400 | 3,924 | 377,610 | 378 K to 377.6 K (-0.11 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.80 | 2,000 | 19,600 | 378,010 | 380 K to 378 K (-0.53 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.79 | 400 | 3,916 | 380,010 | 380.4 K to 380 K (-0.11 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.78 | 300 | 2,934 | 380,410 | 380.7 K to 380.4 K (-0.08 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.75 | 100 | 975 | 380,710 | 380.8 K to 380.7 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 9.74 | 100 | 974 | 380,810 | 380.9 K to 380.8 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.02 | 100 | 1,002 | 380,910 | 381 K to 380.9 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.01 | 100 | 1,001 | 381,010 | 381.1 K to 381 K (-0.03 %) |
| Jul 17 2007 | GYHT | HALOZYME THERAPEUT ... | RAMSAY DAVID A | Secretary, CFO | Sell | S | 10.00 | 300 | 3,000 | 381,110 | 381.4 K to 381.1 K (-0.08 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.94 | 100 | 994 | 92,471 | 92.6 K to 92.5 K (-0.11 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.93 | 600 | 5,958 | 92,571 | 93.2 K to 92.6 K (-0.64 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.92 | 1,100 | 10,912 | 93,171 | 94.3 K to 93.2 K (-1.17 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.91 | 1,100 | 10,901 | 94,271 | 95.4 K to 94.3 K (-1.15 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.90 | 1,100 | 10,890 | 95,371 | 96.5 K to 95.4 K (-1.14 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.89 | 300 | 2,967 | 96,471 | 96.8 K to 96.5 K (-0.31 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.88 | 500 | 4,940 | 96,771 | 97.3 K to 96.8 K (-0.51 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.87 | 800 | 7,896 | 97,271 | 98.1 K to 97.3 K (-0.82 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.86 | 1,100 | 10,846 | 97,271 | 98.4 K to 97.3 K (-1.12 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.85 | 1,000 | 9,850 | 98,071 | 99.1 K to 98.1 K (-1.01 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.83 | 200 | 1,966 | 100,171 | 100.4 K to 100.2 K (-0.20 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.82 | 137 | 1,345 | 100,371 | 100.5 K to 100.4 K (-0.14 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.81 | 200 | 1,962 | 100,508 | 100.7 K to 100.5 K (-0.20 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.80 | 1,363 | 13,357 | 100,708 | 102.1 K to 100.7 K (-1.34 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.79 | 800 | 7,832 | 102,071 | 102.9 K to 102.1 K (-0.78 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.78 | 300 | 2,934 | 102,871 | 103.2 K to 102.9 K (-0.29 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.76 | 100 | 976 | 103,171 | 103.3 K to 103.2 K (-0.10 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.75 | 1,300 | 12,675 | 103,271 | 104.6 K to 103.3 K (-1.24 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.73 | 500 | 4,865 | 104,571 | 105.1 K to 104.6 K (-0.48 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.72 | 800 | 7,776 | 105,071 | 105.9 K to 105.1 K (-0.76 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.71 | 400 | 3,884 | 105,871 | 106.3 K to 105.9 K (-0.38 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.70 | 600 | 5,820 | 106,271 | 106.9 K to 106.3 K (-0.56 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.69 | 300 | 2,907 | 106,871 | 107.2 K to 106.9 K (-0.28 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.68 | 2,782 | 26,930 | 107,171 | 110 K to 107.2 K (-2.53 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.67 | 918 | 8,877 | 109,953 | 110.9 K to 110 K (-0.83 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.66 | 200 | 1,932 | 110,871 | 111.1 K to 110.9 K (-0.18 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.65 | 300 | 2,895 | 111,071 | 111.4 K to 111.1 K (-0.27 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.63 | 300 | 2,889 | 111,371 | 111.7 K to 111.4 K (-0.27 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.62 | 600 | 5,772 | 111,671 | 112.3 K to 111.7 K (-0.53 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 9.61 | 200 | 1,922 | 112,271 | 112.5 K to 112.3 K (-0.18 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 41,812 | 17,979 | 1,046,609 | |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 9.92 | 1,812 | 17,975 | 2,969,606 | 3 M to 3 M (-0.06 %) |
| Jul 11 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 41,812 | 17,979 | 2,971,418 | 2.9 M to 3 M (+1.43 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Option Exercise | M | 0.43 | 26,128 | 11,235 | 1,088,421 | |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 10.00 | 10,000 | 100,000 | 2,929,606 | 2.9 M to 2.9 M (-0.34 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.74 | 1,800 | 17,532 | 2,939,606 | 2.9 M to 2.9 M (-0.06 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.73 | 2,700 | 26,271 | 2,941,406 | 2.9 M to 2.9 M (-0.09 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.73 | 1,400 | 13,615 | 2,944,106 | 2.9 M to 2.9 M (-0.05 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.72 | 300 | 2,917 | 2,945,506 | 2.9 M to 2.9 M (-0.01 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.72 | 800 | 7,776 | 2,945,806 | 2.9 M to 2.9 M (-0.03 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.71 | 1,200 | 11,652 | 2,946,606 | 2.9 M to 2.9 M (-0.04 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.70 | 200 | 1,940 | 2,947,806 | 2.9 M to 2.9 M (-0.01 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.70 | 200 | 1,939 | 2,948,006 | 2.9 M to 2.9 M (-0.01 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.69 | 900 | 8,721 | 2,948,206 | 2.9 M to 2.9 M (-0.03 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.68 | 2,900 | 28,072 | 2,949,106 | 3 M to 2.9 M (-0.10 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.67 | 1,000 | 9,670 | 2,952,006 | 3 M to 3 M (-0.03 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.67 | 200 | 1,933 | 2,953,006 | 3 M to 3 M (-0.01 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.66 | 500 | 4,830 | 2,953,206 | 3 M to 3 M (-0.02 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Sell | S | 9.65 | 900 | 8,685 | 2,953,706 | 3 M to 3 M (-0.03 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Payment of Exercise | F | 9.96 | 1,128 | 11,235 | 2,954,606 | 3 M to 3 M (-0.04 %) |
| Jul 09 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP & Chief Scientif ... | Buy | M | 0.43 | 26,128 | 11,235 | 2,955,734 | 2.9 M to 3 M (+0.89 %) |